about
Concomitant Infections of Influenza A H1N1 and Disseminated Cryptococcosis in an HIV Seropositive Patient.Viral findings in adult hematological patients with neutropenia.Immunogenicity and safety of intradermal influenza vaccine in immunocompromized patients: a meta-analysis of randomized controlled trials.DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation.Ferrets as a Novel Animal Model for Studying Human Respiratory Syncytial Virus Infections in Immunocompetent and Immunocompromised Hosts.Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.Assessment of the Usefulness of Multiplex Real-Time PCR Tests in the Diagnostic and Therapeutic Process of Pneumonia in Hospitalized Children: A Single-Center Experience.The Human Virome - Implications for Clinical Practice in Transplantation Medicine.Antiviral therapy for respiratory viral infections in immunocompromised patients.Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection.A registry of HLA-typed donors for production of virus-specific CD4 and CD8 T lymphocytes for adoptive reconstitution of immune-compromised patients.Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistanceTreatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell TransplantationSevere Respiratory Illness Outbreak Associated with Human Coronavirus NL63 in a Long-Term Care FacilitymTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3Neurologic Alterations Due to Respiratory Virus Infections
P2860
Q30379707-A8C0B6E9-92FE-4D7C-A1F4-CB2E4891B3E9Q34263339-F3FEC172-2762-4CF0-B642-4977EADAF4FAQ35807191-831C7A7B-1D56-4D1A-B638-09D2807A52BAQ36568965-A0FBA754-4105-4B0B-92DB-904EFA793581Q37049972-C8A46499-F2FF-4DD9-85C0-E160FCD9DB1EQ37322142-21C815D5-D8EB-48EC-B694-6EAA6F686EF0Q37611299-5EE2B93D-A232-4EA1-8168-238CC4D33D6AQ38654977-D6820320-0E4B-4019-9E12-386387DE0F98Q39076394-C1111E97-2BCB-40E8-B7A8-2FA8FFA51B98Q40094068-E2B48175-F280-48FE-835E-5A1B7EF5B8BCQ42205114-1BFCC69E-AB80-4410-98A9-986651ECE6C6Q56985884-BDC83784-070B-4209-AD1E-675D321B86FAQ57053316-EA2686F2-A0B2-4033-AF7E-BDA25A031682Q57091765-92E95D80-C50C-4F2E-B15D-4C6644F39658Q57292151-22023E05-F31E-4685-AA83-DEBF30CB2C26Q58707396-EE91C336-C8BF-4D06-9C2D-A17582651C58
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Viral infections in immunocompromised patients.
@en
type
label
Viral infections in immunocompromised patients.
@en
prefLabel
Viral infections in immunocompromised patients.
@en
P2860
P1476
Viral infections in immunocompromised patients.
@en
P2093
Per Ljungman
Tobias Feuchtinger
P2860
P356
10.1016/J.BBMT.2010.11.008
P433
P577
2011-01-01T00:00:00Z